A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics

The European Lung Cancer Working Party (ELCWP) designed a 3-arm phase III randomised trial to determine the role of accelerated chemotherapy in extensive-disease (ED) small-cell lung cancer (SCLC). Eligible patients were randomised between the 3 following arms: (A) Standard chemotherapy with 6 cours...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sculier, J P, Paesmans, M, Lecomte, J, Van Cutsem, O, Lafitte, J J, Berghmans, T, Koumakis, G, Florin, M C, Thiriaux, J, Michel, J, Giner, V, Berchier, M C, Mommen, P, Ninane, V, Klastersky, J
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2001
Assuntos:
Regular Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363948/
https://ncbi.nlm.nih.gov/pubmed/11720426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.2114
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados